Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

3,775 public trials 1,058 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer)

NCT05459129

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • City of Hope Duarte, California, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View Trial Details
Completed

Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

NCT04344795

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +41 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Baystate Gynecologic Oncology Springfield, Massachusetts, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

NCT03929666

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +21 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

NCT04462471

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, BRAF V600E Mutation Positive, +16 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Completed

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

NCT04879849

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • Cedars Sinai Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Laura And Isaac Perlmutter Cancer Center New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View Trial Details

Related conditions